The Society for Immunotherapy of Cancer (SITC) is excited to announce the participants of the inaugural SITC Women in Cancer Immunotherapy Network (WIN) Leadership Institute, scheduled for Aug. 19-20, 2019, in Seattle, Wash.
Kristin G. Anderson, PhD, Fred Hutchinson Cancer Research Center
Maria Libera Ascierto, PhD, Medimmune
Jillian L. Astarita, PhD, Spotlight Therapeutics
Karen Autio, MS, MD, Memorial Sloan Kettering Cancer Center
Challice Bonifant, MD, PhD, John Hopkins University
Tullia C. Bruno, PhD, University of Pittsburgh
Katelyn Byrne, PhD, Parker Institute for Cancer Immunotherapy
Margaret K. Callahan, MD, PhD, Memorial Sloan Kettering Cancer Center
Victoria L. Chiou, MD, U.S. Food and Drug Administration
Heather Cohen, PhD, Jounce Therapeutics
Tricia Cottrell, MD, PhD, John Hopkins University
Lara E. Davis, MD, Oregon Health & Science University
Mihaela Druta, MD, Moffitt Cancer Center
Erin Filbert, PhD, Apexigen, Inc.
Ashley Fritz, PhD, Bristol-Meyers Squibb
Alyssa K. Galaro, PhD, John Hopkins University
Margaret E. Gatti-Mays, MD, MPH, National Cancer Institute
Isabella C. Glitza, MD, PhD, University of Texas MD Anderson Cancer Center
Kathryn A. Gold, MD, University of California San Diego
Jennifer, L. Guerriero, PhD, Dana-Farber Cancer Institute
Silvia Guglietta, PhD, Medical University of South Carolina
Shuchi Gulati, MD, University of Cincinnati Cancer Institute
Heather H. Gustafson, PhD, Seattle Children’s Research Institute
Aparna Hegde, MD, University of Texas MD Anderson Cancer Center
Eda Holl, PhD, RAC, Duke University
Camille Jacqueline, PhD, University of Pittsburgh
Evangelia Katsoulakis, MD, James A. Haley Veterans' Hospital
Laura C. Kennedy, MD, PhD, Fred Hutchinson Cancer Research Center
Shaheen Khan, PhD, UT Southwestern Medical Center
Amanda Kirane, MD, UC Davis Comprehensive Center
Lacey J. Kitch, PhD, Parker Institute for Cancer Immunotherapy
Chrisann Kyi, MD, Memorial Sloan Kettering Cancer Center
Holly A. Martinson, PhD, University of Alaska Anchorage
Shannon L. Maude, MD, PhD, Children’s Hospital of Philadelphia
Jennifer L. McQuade, MD, University of Texas MD Anderson Cancer Center
Kamiya Mehla, PhD, University of Nebraska Medical Center
Amy E. Moran, PhD, Oregon Health & Science University
Rosa Nadal Rios, MD, National Institute of Health
Yana G. Najjar, MD, University of Pittsburgh
Rita Nada, MD, University of Chicago Medicine
Anandani Nellan, MD, Children’s Hospital Colorado
Shannon K. Oda, PhD, Fred Hutchinson Cancer Research Center
Laureen S. Ojalvo, MD, PhD, EMD Serono
Sangeetha Prabhakaran, MD, University of New Mexico
Zoe Quandt, MD, MS, University of California San Francisco
Maria Paula Roberti, PhD, Institut Gustave Roussy
Triparna Sen, PhD, University of Texas MD Anderson Cancer Center
Khyati Shah, PhD, University of California San Francisco
Nirali N. Shah, MD, MHSc, National Institutes of Health
Ann W. Silk, MD, MS, Dana-Farber Cancer Institute
Roberta Sommaggio, PhD, Veneto Institute of Oncology IOV-IRCCS
Christine Spencer, PhD, Parker Institute for Cancer Immunotherapy
Daniela S. Thommen, MD, PhD, The Netherlands Cancer Institute
Rieneke Van de Ven, PhD, VU University Medical Center, Cancer Center Amsterdam
Mireya Paulina Velasquez, MD, St. Jude Children’s Research Hospital
Angela Whatley, PhD, U.S. Food and Drug Administration
Maartje Wouters, PhD, BC Cancer
Yiyi Yan, MD, PhD, Mayo Clinic
Arabella Young, PhD, University of California San Francisco
Roberta Zappasodi, PhD, Memorial Sloan Kettering Institute
Jiajia Zhang, MD, MPH, John Hopkins University
Tian Zhang, MD, Duke University